respiratory
Lung cancer

How checkpoint inhibitors are changing the outlook for lung cancer patients


Immunotherapy is making its mark in the management of lung cancer – the leading cause of cancer deaths in Australia. Survival is being extended for many patients and new agents have just been added to the PBS for patients who have progressed after chemotherapy. The limbic spoke to Dr Leora Horn, Ingram Associate Professor of Medicine ...

Already a member?

Login to keep reading.


OR
© 2019 the limbic